Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD)
Clinical trial NCT05429788 · WITHDRAWN
Trial details
- NCT number
- NCT05429788
- Sponsor
- Receptor Life Sciences
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2022-11-08
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.